| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/14/2004 | CN1511830A Compound used as antiphlogistic |
| 07/14/2004 | CN1511582A Fulong anti-thrombus pill for treating thrombus disease and its preparing process |
| 07/14/2004 | CN1511580A High spirit oral liquid |
| 07/14/2004 | CN1511571A Medicinal composition for preventing and curing hypertension and its preparing method |
| 07/14/2004 | CN1511570A Method for producing brain heat-removing and blood pressure reducing liquid |
| 07/14/2004 | CN1511566A Method for producing cardiotonic anti-senility oral liquid |
| 07/14/2004 | CN1511556A Medicinal composition for treating coronary heart disease and angina pectoris |
| 07/14/2004 | CN1511555A Medicinal composition for treating coronary heart disease and angine pectoris |
| 07/14/2004 | CN1511539A Dogwood fruit extract and its preparing method and use |
| 07/14/2004 | CN1511535A Use of spirosterol type steroid saponin in preparing medicine for treating cardio-cerebral vascular disease |
| 07/14/2004 | CN1511534A Total sanchinoside and ferulic acid composition for treating cardio-cerebral vascular disease and diabetes and its use |
| 07/14/2004 | CN1511533A Use of bufadienolide in inhibiting vascularization |
| 07/14/2004 | CN1511531A Use of homoharringtonine and harringtonine in inhibiting vascularization |
| 07/14/2004 | CN1511529A Medicine for treating cerebrovascular desease |
| 07/14/2004 | CN1511524A Indapamide slow-releasing capsule and its preparing process |
| 07/14/2004 | CN1511521A Use of goldenlarch bark acetic acid inhibiting vascularization |
| 07/14/2004 | CN1157415C Alginate having low molecular weight, method for manufacturing it and its use |
| 07/14/2004 | CN1157392C 8-Azabicyclo (3,2,1) oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACH receptors |
| 07/14/2004 | CN1157390C Indole derivant |
| 07/14/2004 | CN1157380C Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulants agents |
| 07/14/2004 | CN1157378C Qunoline derivatives |
| 07/14/2004 | CN1157376C Arylpiperidinopropanol and arylpiperaznipropanol derivatives and pharmaceuticals containing the same |
| 07/14/2004 | CN1157372C Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as medicament and pharmaceutical preparations containing the same |
| 07/14/2004 | CN1157368C Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor (PPAR)a |
| 07/14/2004 | CN1157221C Health compsn. |
| 07/14/2004 | CN1157188C Method for inhibiting stress-activated protein kinases |
| 07/13/2004 | USRE38556 Recombinant adeno viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias |
| 07/13/2004 | US6762284 Used for medical applications, including diagnosis and treatment cell growth disorders like restenosis and cancer |
| 07/13/2004 | US6762283 Caspase-8 interacting proteins |
| 07/13/2004 | US6762200 Phospholipase inhibitors |
| 07/13/2004 | US6762196 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
| 07/13/2004 | US6762195 Treating diseases mediated by tumor necrosis factor; inhibit angiogenesis and treatment of cancer, inflammatory, and autoimmune diseases |
| 07/13/2004 | US6762191 Therapeutic compounds |
| 07/13/2004 | US6762186 Use to treat allergy, nasal congestion, inflammatory and central nervous system-related diseases |
| 07/13/2004 | US6762176 Inhibiting no-synthase enzymes producing nitrogen monoxide and/or trapping reactive forms of oxygen; inhibit lipidic peroxidation |
| 07/13/2004 | US6762165 Snail venom; muscular disorders, central nervous system disorders, cardiovascular disorders |
| 07/13/2004 | US6761878 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 07/13/2004 | CA2386775C Drugs for the treatment of malignant tumours |
| 07/13/2004 | CA2348882C Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol |
| 07/13/2004 | CA2268684C Process for alkylating hindered sulfonamides |
| 07/08/2004 | WO2004056991A2 Novel angiogenic molecular target and uses thereof |
| 07/08/2004 | WO2004056869A1 Ghrelin receptor inverse agonist for regulation of feeding behaviours |
| 07/08/2004 | WO2004056787A1 Cyclopentyl glutaramides and their use as neutral endopeptidase inhibitors |
| 07/08/2004 | WO2004056777A1 Microsomal triglyceride transfer protein inhibitors |
| 07/08/2004 | WO2004056376A1 Pharmaceutical formulations containing nitrate |
| 07/08/2004 | WO2004056368A1 Therapeutic applications of 2-substituted 4-heteroarylryrimidines |
| 07/08/2004 | WO2004056353A2 Device and method for delivering mmp inhibitors |
| 07/08/2004 | WO2004037791B1 Inhibitors of glycogen synthase kinase 3 |
| 07/08/2004 | WO2004037184A3 Methods for the treatment of skin disorders |
| 07/08/2004 | WO2004017920A3 Novel biphenyl and biphenyl-like cannabinoids |
| 07/08/2004 | WO2004012759B1 Use of erythropoietin |
| 07/08/2004 | WO2004012653A3 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 07/08/2004 | WO2004009072B1 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 07/08/2004 | WO2004007498A3 3-phenyl analogs of toxoflavine as kinase inhibitors |
| 07/08/2004 | WO2004006853A3 Treatment and prophylaxis with 4-1bb-binding agents |
| 07/08/2004 | WO2003106628A3 Benzodiazepine inhibitors of mitochondial f¿1<f¿0? atp hydrolase and methods of inhibiting f¿1?f¿0? atp hydrolase |
| 07/08/2004 | WO2003105771A3 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 07/08/2004 | WO2003103663A3 Substituted pyrrolines as kinase inhibitors |
| 07/08/2004 | WO2003092625A3 Carvedilol formulations |
| 07/08/2004 | WO2003066822A3 Truncated aggrecanase molecules |
| 07/08/2004 | WO2003046204A8 Humanized collagen antibodies and related methods |
| 07/08/2004 | WO2003042358A3 Methods of using 48149, a human aminopeptidase family member |
| 07/08/2004 | WO2003039553B1 Compositions for treatment of postmenopausal female sexual dysfunction |
| 07/08/2004 | WO2003002058A9 Bone anabolic compounds and methods of use |
| 07/08/2004 | WO2002097060A3 Carbohydrate-associated proteins |
| 07/08/2004 | US20040133000 Process for the preparation of oxabispidines |
| 07/08/2004 | US20040132988 Immunoeffector compounds |
| 07/08/2004 | US20040132973 for gene therapy and vaccination; enzyme-linked immunosorbent assay (ELISA); kits; genetic engineering |
| 07/08/2004 | US20040132830 Antiproliferative agents; anticancer agents; antiinflammatory agents; autoimmune diseases |
| 07/08/2004 | US20040132822 Crystalline solid form of (2S,5Z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 07/08/2004 | US20040132806 polymeric coating with a pH-independent dissolution profile that inhibits the release of the pravastatin in the stomach, and permits release in the intestine; side effect reduction |
| 07/08/2004 | US20040132805 preferably also contains a compound that donates, transfers, releases or induces production of nitric oxide and a hydralazine antioxidant; for treating and/or preventing a vascular disease characterized by nitric oxide insufficiency |
| 07/08/2004 | US20040132798 containing a benzonitrile group and N-substituted with a tert-butylcarbonylmethyl- or a tert-butyloxycarbonylaminoethyl- group; particularly in a gelling polymer matrix to form modified release composition |
| 07/08/2004 | US20040132789 Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin |
| 07/08/2004 | US20040132787 e.g., 2-methyl-2-{4-[3-(4-tert-Butyl-phenyl)-[1,2,4]oxadiazol-5-ylmethoxy]-2-methyl-phenoxy}propionic acid or its ethyl ester; dyslipidemia, syndrome X, heart failure, hypercholesteremia, cardiovascular disease, diabetes, anorexia, etc. |
| 07/08/2004 | US20040132783 Method of examining effect of angiogenesis inhibitors mediated by the inhibition of integrin expression |
| 07/08/2004 | US20040132781 Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2004 | US20040132770 Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen |
| 07/08/2004 | US20040132745 carbamoyl-substituted aromatics, e.g., N-(butylcarbamoyl-phenyl-methyl)-6-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-nicotinamide; treating hypercholesterolemia, hypertriglyceridemia, pancreatitis, obesity and diabetic conditions |
| 07/08/2004 | US20040132735 Beta-carboline derivatives and its pharmaceutical use aginst depression and anxiety |
| 07/08/2004 | US20040132729 Inhibitors of p38 |
| 07/08/2004 | US20040132727 Quinoline and quinazoline derivatives and drugs containing the same |
| 07/08/2004 | US20040132725 tyrphostin preparations enriched in certain geometric isomers; treating protein tyrosine kinase related disorders. especially with slow release formulations |
| 07/08/2004 | US20040132720 Antidepressants |
| 07/08/2004 | US20040132710 Lactams as tachkinin antagonists |
| 07/08/2004 | US20040132705 Inhibitors of thromboxane formation and action |
| 07/08/2004 | US20040132694 6-Chloro-3-(3,4-dioxo-2-phenylamino-cyclobut-1-enylamino)-2-hydroxy-benzamide; psoriasis, atopic dermatitis, arthritis, asthma, chronic obstructive pulmonary disease, adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease |
| 07/08/2004 | US20040132686 C2,5'- disubstituted and N6, c2,5'- trisubstituted adenosine derivatives and their different uses |
| 07/08/2004 | US20040132669 Glycopyranosyloxypyrazole derivatives and medicinal use thereof |
| 07/08/2004 | US20040132639 Dipeptidyl peptidaseIV and alanyl-aminopeptidase inhibitors |
| 07/08/2004 | US20040132636 Pharmaceutical uses for alpha2delta ligands |
| 07/08/2004 | US20040132163 Biological materials and uses thereof |
| 07/08/2004 | US20040132140 comprises using a cell resistant to a lectin which recognizes a sugar chain in which 1-position of fucose is bound to 6-position of N-acetylglucosamine in the reducing end through alpha -bond in a complex N-glycoside-linked sugar chain |
| 07/08/2004 | US20040132139 Comprises nucleotide sequences coding protein with antiproliferative and viricidal activity for use in treatment and prevention of cancer, nervous system, bone and autoimmune disorders |
| 07/08/2004 | US20040132093 Comprises cytokine receptor fusion protein for use in indentifying modulators for treatment of bone disorders |
| 07/08/2004 | US20040132053 Sphingosine kinase enzyme |
| 07/08/2004 | US20040132038 Membrane protein for use as diagnostic tool in the detection and prevention of cell proliferative, cardiovascular, skin, nervous system, respiratory and metabolic disorders |
| 07/08/2004 | US20040132022 Comprises nucleotide sequences coding growth factor for treatment and prevention of aberrations in cellular growth and differentiation; cancer diagnosis and treatment; antitumor agents |
| 07/08/2004 | US20040131733 solubilisation of lycopene in this supercritical fluid and to separate the lycopene concentrate by depressurisation carried out at pressures below 10 MPa to produce an oleoresin |
| 07/08/2004 | US20040131703 Antiinflammatory agents; respiratory system disorders |